Cargando…
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
Although inoculation of COVID-19 vaccines has rolled out globally, there is still a critical need for safe and effective vaccines to ensure fair and equitable supply for all countries. Here, we report on the development of a highly efficacious mRNA vaccine, SW0123 that is composed of sequence-modifi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165147/ https://www.ncbi.nlm.nih.gov/pubmed/34059617 http://dx.doi.org/10.1038/s41392-021-00634-z |
_version_ | 1783701253621022720 |
---|---|
author | Yang, Ren Deng, Yao Huang, Baoying Huang, Lei Lin, Ang Li, Yuhua Wang, Wenling Liu, Jingjing Lu, Shuaiyao Zhan, Zhenzhen Wang, Yufei A, Ruhan Wang, Wen Niu, Peihua Zhao, Li Li, Shiqiang Ma, Xiaopin Zhang, Luyao Zhang, Yujian Yao, Weiguo Liang, Xingjie Zhao, Jincun Liu, Zhongmin Peng, Xiaozhong Li, Hangwen Tan, Wenjie |
author_facet | Yang, Ren Deng, Yao Huang, Baoying Huang, Lei Lin, Ang Li, Yuhua Wang, Wenling Liu, Jingjing Lu, Shuaiyao Zhan, Zhenzhen Wang, Yufei A, Ruhan Wang, Wen Niu, Peihua Zhao, Li Li, Shiqiang Ma, Xiaopin Zhang, Luyao Zhang, Yujian Yao, Weiguo Liang, Xingjie Zhao, Jincun Liu, Zhongmin Peng, Xiaozhong Li, Hangwen Tan, Wenjie |
author_sort | Yang, Ren |
collection | PubMed |
description | Although inoculation of COVID-19 vaccines has rolled out globally, there is still a critical need for safe and effective vaccines to ensure fair and equitable supply for all countries. Here, we report on the development of a highly efficacious mRNA vaccine, SW0123 that is composed of sequence-modified mRNA encoding the full-length SARS-CoV-2 Spike protein packaged in core–shell structured lipopolyplex (LPP) nanoparticles. SW0123 is easy to produce using a large-scale microfluidics-based apparatus. The unique core–shell structured nanoparticle facilitates vaccine uptake and demonstrates a high colloidal stability, and a desirable biodistribution pattern with low liver targeting effect upon intramuscular administration. Extensive evaluations in mice and nonhuman primates revealed strong immunogenicity of SW0123, represented by induction of Th1-polarized T cell responses and high levels of antibodies that were capable of neutralizing not only the wild-type SARS-CoV-2, but also a panel of variants including D614G and N501Y variants. In addition, SW0123 conferred effective protection in both mice and non-human primates upon SARS-CoV-2 challenge. Taken together, SW0123 is a promising vaccine candidate that holds prospects for further evaluation in humans. |
format | Online Article Text |
id | pubmed-8165147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81651472021-06-01 A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity Yang, Ren Deng, Yao Huang, Baoying Huang, Lei Lin, Ang Li, Yuhua Wang, Wenling Liu, Jingjing Lu, Shuaiyao Zhan, Zhenzhen Wang, Yufei A, Ruhan Wang, Wen Niu, Peihua Zhao, Li Li, Shiqiang Ma, Xiaopin Zhang, Luyao Zhang, Yujian Yao, Weiguo Liang, Xingjie Zhao, Jincun Liu, Zhongmin Peng, Xiaozhong Li, Hangwen Tan, Wenjie Signal Transduct Target Ther Article Although inoculation of COVID-19 vaccines has rolled out globally, there is still a critical need for safe and effective vaccines to ensure fair and equitable supply for all countries. Here, we report on the development of a highly efficacious mRNA vaccine, SW0123 that is composed of sequence-modified mRNA encoding the full-length SARS-CoV-2 Spike protein packaged in core–shell structured lipopolyplex (LPP) nanoparticles. SW0123 is easy to produce using a large-scale microfluidics-based apparatus. The unique core–shell structured nanoparticle facilitates vaccine uptake and demonstrates a high colloidal stability, and a desirable biodistribution pattern with low liver targeting effect upon intramuscular administration. Extensive evaluations in mice and nonhuman primates revealed strong immunogenicity of SW0123, represented by induction of Th1-polarized T cell responses and high levels of antibodies that were capable of neutralizing not only the wild-type SARS-CoV-2, but also a panel of variants including D614G and N501Y variants. In addition, SW0123 conferred effective protection in both mice and non-human primates upon SARS-CoV-2 challenge. Taken together, SW0123 is a promising vaccine candidate that holds prospects for further evaluation in humans. Nature Publishing Group UK 2021-05-31 /pmc/articles/PMC8165147/ /pubmed/34059617 http://dx.doi.org/10.1038/s41392-021-00634-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Yang, Ren Deng, Yao Huang, Baoying Huang, Lei Lin, Ang Li, Yuhua Wang, Wenling Liu, Jingjing Lu, Shuaiyao Zhan, Zhenzhen Wang, Yufei A, Ruhan Wang, Wen Niu, Peihua Zhao, Li Li, Shiqiang Ma, Xiaopin Zhang, Luyao Zhang, Yujian Yao, Weiguo Liang, Xingjie Zhao, Jincun Liu, Zhongmin Peng, Xiaozhong Li, Hangwen Tan, Wenjie A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity |
title | A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity |
title_full | A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity |
title_fullStr | A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity |
title_full_unstemmed | A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity |
title_short | A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity |
title_sort | core-shell structured covid-19 mrna vaccine with favorable biodistribution pattern and promising immunity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165147/ https://www.ncbi.nlm.nih.gov/pubmed/34059617 http://dx.doi.org/10.1038/s41392-021-00634-z |
work_keys_str_mv | AT yangren acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT dengyao acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT huangbaoying acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT huanglei acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT linang acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT liyuhua acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT wangwenling acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT liujingjing acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT lushuaiyao acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhanzhenzhen acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT wangyufei acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT aruhan acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT wangwen acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT niupeihua acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhaoli acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT lishiqiang acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT maxiaopin acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhangluyao acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhangyujian acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT yaoweiguo acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT liangxingjie acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhaojincun acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT liuzhongmin acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT pengxiaozhong acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT lihangwen acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT tanwenjie acoreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT yangren coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT dengyao coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT huangbaoying coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT huanglei coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT linang coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT liyuhua coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT wangwenling coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT liujingjing coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT lushuaiyao coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhanzhenzhen coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT wangyufei coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT aruhan coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT wangwen coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT niupeihua coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhaoli coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT lishiqiang coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT maxiaopin coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhangluyao coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhangyujian coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT yaoweiguo coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT liangxingjie coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT zhaojincun coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT liuzhongmin coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT pengxiaozhong coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT lihangwen coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity AT tanwenjie coreshellstructuredcovid19mrnavaccinewithfavorablebiodistributionpatternandpromisingimmunity |